The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human phase I/II trial of PRGN-2009 vaccine as monotherapy or with bintrafusp alfa in patients with recurrent/metastatic (R/M) human papillomavirus (HPV)-associated cancers (HPVC) and as neoadjuvant/induction therapy in locoregionally advanced (LA) HPV oropharyngeal (OP) and sinonasal (SN) squamous cell cancer (SCC).
 
Charalampos S. Floudas
No Relationships to Disclose
 
Julius Strauss
Research Funding - Bavarian Nordic (Inst); EMD Serono (Inst); ImmunityBio (Inst); PDS Biotechnology (Inst); Precigen (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on NIH pending patent (Inst)
 
Clint Allen
No Relationships to Disclose
 
Nyall R London
Stock and Other Ownership Interests - Navigen Pharmaceuticals
Consulting or Advisory Role - CoolTech Medical
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - Navigen Pharmaceuticals
 
Renee Nicole Donahue
No Relationships to Disclose
 
Caroline Jochems
No Relationships to Disclose
 
Seth M. Steinberg
No Relationships to Disclose
 
Lisa M. Cordes
No Relationships to Disclose
 
Sheri McMahon
No Relationships to Disclose
 
Jenn Marte
No Relationships to Disclose
 
Houssein Abdul Sater
No Relationships to Disclose
 
Jason Redman
No Relationships to Disclose
 
Fatima Karzai
No Relationships to Disclose
 
Marijo Bilusic
Research Funding - Bavarian Nordic (Inst); ImmunityBio (Inst); NextCure (Inst)
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)
Research Funding - Bayer
 
Douglas E Brough
Employment - Precigen
Leadership - Precigen
Stock and Other Ownership Interests - Precigen
Patents, Royalties, Other Intellectual Property - Precigen
 
Amy Lankford
Employment - Precigen
Stock and Other Ownership Interests - Precigen; Precigen
 
Jeffrey Schlom
Research Funding - Bavarian Nordic (Inst); EMD Serono/Merck (Inst); ImmunityBio (Inst); Incyte (Inst); NextCure (Inst); PDS Biotechnology (Inst); Precigen (Inst)
Patents, Royalties, Other Intellectual Property - If applicable; If applicable (Inst)
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); ImmunityBio (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst)